Masood Umair, Sharma Anuj, Nijjar Sonny, Krenzer Barbara
Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
J Basic Clin Pharm. 2016 Dec;8(1):38-39. doi: 10.4103/0976-0105.195126.
A 57-year-old male with a history of alcoholism presented to the emergency room with abdominal pain, jaundice, transaminitis, and hyperbilirubinemia. Due to the history of alcoholism, it was initially presumed that the patient had alcoholic hepatitis but further investigation revealed that he was recently started on sulfasalazine for the treatment of rheumatoid arthritis. Upon cessation of the drug, the patient's liver function tests significantly improved over a few days and eventually normalized within weeks. This case was interesting as the patient's history of alcoholism disguised the actual diagnosis. Furthermore, the late presentation of sulfasalazine-induced liver injury is uncommon as it commonly presents 2-4 weeks after initiation of therapy.
一名有酗酒史的57岁男性因腹痛、黄疸、转氨酶升高和高胆红素血症就诊于急诊室。由于有酗酒史,最初推测该患者患有酒精性肝炎,但进一步检查发现他最近开始服用柳氮磺胺吡啶治疗类风湿性关节炎。停药后,患者的肝功能检查在几天内显著改善,并最终在几周内恢复正常。该病例很有意思,因为患者的酗酒史掩盖了实际诊断。此外,柳氮磺胺吡啶所致肝损伤的迟发性表现并不常见,因为它通常在治疗开始后2 - 4周出现。